Linking diabetic cardiovascular disease with non-alcoholic fatty liver disease through L-carnitine: A hyperpolarized MRS study

Documenti analoghi

• The importance of the fatty acid transporter L-carnitine in non-alcoholic fatty liver disease (NAFLD)
  di: Savic, D, et al.
  Pubblicazione: (2020)
• L-Carnitine stimulates in vivo carbohydrate metabolism in the Type 1 diabetic heart as demonstrated by hyperpolarized MRI
  di: Savic, D, et al.
  Pubblicazione: (2021)
• Simultaneous in vivo assessment of cardiac and hepatic metabolism in the diabetic rat using hyperpolarized MRS
  di: Le Page, L, et al.
  Pubblicazione: (2016)
• Detection and alterations of acetylcarnitine (AC) in human liver by 1H MRS at 3T after supplementation with L-carnitine
  di: Savic, D, et al.
  Pubblicazione: (2022)
• Non-alcoholic fatty liver disease
  di: Pavlides, M, et al.
  Pubblicazione: (2019)